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O B J E C T I V E S The aim of this study was to image expression of receptor for advanced glycation
end products (RAGE) in a mouse model of myocardial reperfusion injury.
B A C KG ROUND RAGE and its ligands are implicated in the pathogenesis of ischemia/reperfusion
injury and infarction. We hypothesized that RAGE-directed quantitative imaging of myocardial uptake of
technetium-99m (99mTc)-anti-RAGE F(ab’)2 in a mouse model of myocardial ischemic injury can detect
RAGE expression and show quantitative differences between early (18 to 20 h) and later times (48 h) after
reperfusion.
METHOD S Twenty-ﬁve wild-type (WT) mice underwent left anterior descending coronary artery
occlusion for 30 min. Mice were injected with 19.98  1.78 MBq of 99mTc anti-RAGE F(ab’)2 at 2 time
points after reperfusion (at 18 to 20 h [n  8] and at 48 h [n  12]) and 5 h later with 6.14  2.0 MBq
of thallium-201 (201Tl). Five WT mice were injected with nonspeciﬁc F(ab’)2 and
201Tl 18 to 20 h after
reperfusion. Six WT mice underwent sham operation without coronary intervention. After injection with
201Tl, all mice immediately underwent dual isotope single-photon emission computed tomography/
computed tomography. At completion of imaging, hearts were counted and sectioned.
R E S U L T S The uptake of 99mTc-anti-RAGE F(ab’)2 in the ischemic zone from the scans as mean
percentage injected dose was signiﬁcantly greater at 18 to 20 h (5.7  2.1  103%) as compared with
at 48 h (1.4 1.1 103%; p 0.001) after reperfusion. Disease and antibody controls showed no focal
uptake in the infarct. Gamma well counting of the myocardium supported the quantitative scan data. By
immunohistochemical staining there was greater caspase-3 and RAGE staining at 18 to 20 h versus at
48 h (p  0.04 and p  0.01, respectively). On dual immunoﬂuorescence, RAGE colocalized mainly with
injured cardiomyocytes undergoing apoptosis.
CONC L U S I O N S RAGE expression in myocardial ischemic injury can be imaged in vivo using a
novel 99mTc-anti-RAGE F(ab’)2. RAGE plays a role in several cardiovascular diseases and is a potential
target for clinical imaging. (J Am Coll Cardiol Img 2012;5:59–67) © 2012 by the American College of
Cardiology Foundation
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60yocardial infarction and its conse-
quences are a leading cause of morbid-
ity and mortality. Previous studies have
shown that receptor for advanced gly-
ation end products (RAGE) and its ligands have
een implicated in the pathogenesis of myocardial
schemic damage and reperfusion injury (1). The
inding of products of nonenzymatic glycation and
ther proinflammatory and tissue destructive li-
ands to RAGE, a receptor of the immunoglobulin
uperfamily of cell surface molecules, triggers many
See page 68
important downstream pathways impli-
cated in inflammation as well as renal
failure, aging, cancer, and diabetes (2–6).
A novel peptide sequence on the
V-domain of the extracellular receptor of
RAGE was first characterized by Neper et
al. (2). Using this peptide as antigen, a
monoclonal antibody to RAGE was de-
veloped using hybridoma technology
(Strategic BioSolutions, Newark, Dela-
ware).
The present study was undertaken to
test the hypothesis that RAGE expression
in injured myocardium can be imaged
in vivo using this radiolabeled anti-RAGE
antibody fragment and that quantification
of radiotracer uptake can track changes in
receptor expression. Such noninvasive
tracking of RAGE expression in myocar-
dial infarction in a relevant animal model
may provide a platform for assessing tar-
geted drug therapy to reduce myocardial
damage and could provide a noninvasive
imaging strategy for patients.
M E T H O D S
Development of monoclonal anti-RAGE antibody. We
eveloped a novel antibody in mice against the
-domain of RAGE designed to display immuno-
eactivity in mice, pigs, and humans. Based on
enbank sequences of human, murine, and porcine
AGE, a sequence alignment was determined and
eptide prepared consisting of 17 amino acids:
-NRRGKEVKSNYRVRVYQIC-19. Mice were
mmunized with the peptide and spleens harvested
o produce hybridomas for murine monoclonal
ntibody (IgG2a,k) production (Strategic Diagnos-
end
tic
d
ing
y
edics, Newark, Delaware). The monoclonal anti- sAGE antibody was fragmented using pepsin di-
estion into F(ab’)2 fragments (approximately 110
kDa) and immunoreactivity tested by enzyme-
linked immunosorbent assay using soluble RAGE
antigen. Direct coupling of diethylenetriaminepen-
taacetic acid (DTPA) (bicyclic anhydride) to anti-
RAGE F(ab’)2 antibody fragments for technetium-
9m (99mTc) labeling was performed. Blood pool
clearance allows imaging at 4 to 5 h after injection (7).
Animals. Male C57BL/6 mice (8 to 10 weeks old)
n  31) were obtained from Jackson Laboratories
Bar Harbor, Maine). All animal procedures were
pproved by the Institutional Animal Care and Use
ommittee of Columbia University. The experi-
ental protocol is outlined in Figure 1.
Surgical procedures. Mice underwent 30-min left
nterior descending artery (LAD) occlusion (n 
5) or sham surgery (n  6) followed by reperfu-
ion. Briefly, mice were anesthetized with ketamine
100 mg/kg) and xylazine (5 mg/kg intraperitone-
lly), intubated, and ventilated with room air using
rodent miniventilator (Harvard Apparatus, Hol-
iston, Massachusetts). A left thoracotomy was
erformed, and the heart was accessed between the
hird and fourth intercostal space. An 8-0 Prolene
uture was placed around the LAD immediately
fter the bifurcation of the major left coronary
rtery and ligated for 30 min. The ligature was then
emoved, and blood flow was restored. The chest
avity was closed, and the animals were allowed to
ecover.
Radiotracer preparation. Direct labeling of the anti-
body fragment with DTPA for 99mTc labeling was
ndertaken as previously described (7,8). The mean
pecific activity was 8.14 3.8 MBq/g of protein,
nd the mean radiopurity was 98  0.83% by
nstant thin-layer chromatography. To localize the
n vivo antibody uptake by histology, DTPA-
abeled anti-RAGE F(ab’)2 was conjugated to rho-
amine isothiocyanate and purified as previously
eported (7).
Injection and imaging. Mice were anesthetized and
njected with 19.98  1.78 MBq of 99mTc-labeled
nti-RAGE F(ab’)2 via femoral vein catheter at 18
o 20 h (n  8) or 48 h (n  12) after reperfusion
or sham surgery (n  6). Five additional mice were
injected with purified nonimmune mouse IgG
F(ab’)2 (Alpha Diagnostic, San Antonio, Texas) at
18 to 20 h after reperfusion. Five hours later, each
animal was re-anesthetized and injected with 6.14 
2.0 MBq of thallium-201 (201TI) and immediately
nderwent dual isotope hybrid single-photon emis-A B B R E V I A T I O N S
A N D A C R O N YM S
AGEs advanced glycation
products
DTPA
diethylenetriaminepentaace
acid
%ID percentage of injecte
dose
FITC fluorescein
isothiocyanate
LAD left anterior descend
artery
LV left ventricle
mAbmonoclonal antibod
RAGE receptor for advanc
glycation end products
ROIs regions of interest
SPECT/CT single-photon
emission computed
tomography/computed
tomography
99mTc technetium-99mion computed tomography/computed tomography
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61(SPECT/CT) imaging using both the 99mTc pho-
opeak (140 keV) and the 201TI photopeak (68
eV).
Helical SPECT/CT images were acquired with
ual-headed sodium iodide (TI) detectors, each
utfitted with 9 pinholes. Each pinhole had a
Figure 2. Imaging of RAGE Expression After Reperfusion
Representative coronal (top panels) and transverse (bottom panels
injected with 99mTc-labeled anti-RAGE F(ab’)2 and
201Tl at 18 to 20
reperfusion. Uptake of 99mTc is designated by red and uptake of 20
becomes yellow. Uptake of the 99mTc-anti-RAGE F(ab’)2 is seen in th
it is shown to be greater at 18 to 20 h after reperfusion. Disease an
Figure 1. Schematic Diagram of the Experimental Protocol
LAD  left anterior descending artery; RAGE  receptor for advanc
puted tomography/computed tomography; 99mTc  technetium-99zone. Abbreviations as in Figure 1.iameter of 1.4 mm, with each collimator providing
transaxial field of view of 30 mm and an axial field
f view of 16 mm, extendable through helical
canning to 270 mm. A topogram (sequence of
-dimensional side view x-ray projections) was used
o determine the axial scan range for SPECT and
brid SPECT/CT images in mice with 30-min LAD occlusion and
at 48 h or with control nonspeciﬁc F(ab’)2 at 18 to 20 h after
y green. When merged, overlapping uptake of the 2 tracers
order of the apical defect (arrows) at both time points, although
ntibody controls showed no focal tracer uptake in the infarct
lycation end products; SPECT/CT  single-photon emission com-
01Tl  thallium-201.) hy
h or
1Tl b
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62CT imaging. The acquisition was set up with the
following parameters: step and shoot rotation, 30°
step in 360° rotation using 24 projections, 60 per
projection, and a 256  256 frame size with 1.0
mm pixels. The obtained projection data were
reconstructed iteratively with ordered subsets ex-
pectation maximization algorithm. CT scans were
performed using a tube voltage of 45 keV and an
exposure time of 1,000 ms per view. The CT and
SPECT data were fused and reconstructed using
InVivoScope software.
Image analyses. Simultaneously acquired 201TI and
99mTc reconstructed transverse slices were displayed
for uptake of 99mTc-anti-RAGE antibody in rela-
ionship to 201TI uptake that delineates perfused
myocardium. Regions of interest (ROIs) on the
transverse projections were drawn around focal
areas of 99mTc uptake and counts from the ROIs
onverted to microcuries (Ci) using InVivoScope
oftware. The system is calibrated for absolute
uantification using specially designed mouse-
haped phantoms filled with known levels of 99mTc
maged with the same protocol used for the animal
tudies. The quantitative uptake in the infarcted
yocardium converted to megabecquerel (MBq)
as divided by the total injected dose to obtain
ercentage of injected dose (%ID). Regions were
lso drawn around 201TI uptake on the coronal
rojections to calculate total myocardial left ventri-
le (LV) volume and volume of the section of
yocardium that included the ischemic zone to
alculate %ID per gram (%ID/g), assuming the
pecific gravity of heart is similar to water and equal
o 1.0.
Gamma well counting. After the final imaging ses-
ion, the animals were sacrificed, tissue samples
rom the heart were excised and weighed, and the
adioactivity was counted in a gamma counter
Wallac Wizard 1470, PerkinElmer, Boston, Mas-
achusetts) for determination of the %ID/g of
issue. The radiotracer activity in the samples was
orrected for background, decay time, and tissue
eight.
Histochemical analysis. Pathological characterization
f the heart was undertaken by histology and
mmunohistochemical staining. Serial sections
5-m thick) from paraffin-embedded hearts
ere stained with hematoxylin and eosin and
xamined with 20 magnification using a micro-
cope. The infarct area was expressed as a per-
entage of the total myocardium. For immuno-
istochemical staining, deparaffinized tissue
ections were treated with 0.3% hydrogen perox-de to block endogenous peroxidase activity. Tis-
ue sections were then incubated in protein-free
lock (Dako, Carpinteria, California) for 10 min
o inhibit the nonspecific binding of primary
ntibodies. Sections were examined for the pres-
nce of RAGE (anti-RAGE antibody fragment),
eukocytes (myeloperoxidase; Abcam, Cam-
ridge, Massachusetts), and apoptosis (-active
aspase-3; Promega, Madison, Wisconsin). Sec-
ndary stains were performed using avidin-biotin
isualization systems (Vectastain ABC Kit, Vec-
or Laboratories, Burlingame, California).
Immunostains were examined using a Nikon
icroscope (Nikon, Tokyo, Japan), and digital
mages were analyzed using Image-Pro Plus soft-
are (Media Cybernetics Inc., Bethesda, Mary-
and). Infarct areas stained positive for a particular
hromogen were identified using a color recogni-
Figure 3. Quantitative Myocardial Uptake of
99mTc-anti-RAGE F(ab’)2
(A) The focal uptake from the scans as a percentage of injected
dose (%ID) was signiﬁcantly greater at 18 to 20 h than at 48 h
after reperfusion (p  0.001). (B) Uptake as %ID from scan cor-
related signiﬁcantly with %ID/g from well counting. Error bars
represent  1 SD. Abbreviations as in Figure 1.
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63tion method and measured by averaging results for
3 representative high-powered fields (100) in
each tissue cross section.
Immunoﬂuorescence. Dual-label confocal micros-
opy was performed to determine the cell types
xpressing RAGE in the infarcted myocardium.
yocardial sections were stained to visualize im-
unofluorescent colocalization of RAGE (anti-
AGE, Texas red) with endothelial cells (FVIII,
uorescein isothiocyanate [FITC]), leukocytes
myeloperoxidase, FITC), smooth muscle cells (-
actin, FITC), cardiomyocytes (-sarcomeric actin,
FITC), apoptotic cells (-active caspase-3, FITC),
and with injured myocytes (-myosin antibody,
ITC). Counterstaining with 4’,6-diamidino-2-
henylindole (blue) was performed to identify nu-
lei. To localize uptake of the radiolabeled antibody
y histology, DTPA-labeled anti-RAGE F(ab’)2
was conjugated to rhodamine isothiocyanate and
labeled with 99mTc.
Statistical analysis. Continuous variables were ex-
ressed as mean  SD. Normality was assessed
sing the Shapiro-Wilk W test. Equality of vari-
nces was assessed using the Levene test. Compar-
sons between groups were made using the Student
test or the Mann-Whitney U test, as appropriate.
orrelation was assessed using the Pearson
roduct-moment correlation coefficient. All statis-
ical tests were 2-tailed, with p  0.05 denoting
ignificance. Statistical analyses were performed
Figure 4. Bar Graphs of Biodistribution Data
Bar graphs of biodistribution data showing mean percentage of inj
6 h after tail vein injection of radiolabeled anti-RAGE F(ab’)2 (green
reperfusion. Abbreviations as in Figure 1.sing STATA 10.1 (StataCorp, College Station,
exas).
R E S U L T S
SPECT/CT imaging. On the reconstructed scans from
mice injected with 99mTc-anti-RAGE F(ab’)2, the
signal from the radiolabeled antibody was detected
in the ischemic zone delineated as a 201TI defect
Fig. 2). Tracer uptake in the ischemic region from
he scans was higher in mice imaged at 18 to 20 h
fter reperfusion as compared with those imaged at
8 h (5.7  2.1  103 %ID vs. 1.4  1.1  103
%ID; p 0.001). The sham-operated mice showed
no focal uptake of the radiolabeled anti-RAGE
antibody in the region of the infarct. The mice
injected with 99mTc-nonspecific F(ab’)2 after LAD
occlusion and reperfusion at 18 to 20 h also showed
no focal uptake.
Gamma well counting. The higher uptake of the
99mTc-anti-RAGE F(ab’)2 in the ischemic zone at
18 to 20 h was confirmed by ex vivo gamma
counting. There was a significant difference be-
tween myocardial counts from mice injected at 18 to
20 h after reperfusion (1.21  0.41 %ID/g) and mice
injected 48 h after reperfusion (0.31  0.08 %ID/g;
p  0.007) (Fig. 3A). Counts from hearts injected
with 99mTc-control nonspecific F(ab’)2 (0.14  0.10
%ID/g) were significantly lower (p  0.02).
d dose per gram (%ID/g) in non-target organs of wild-type mice
s) or control nonspeciﬁc F(ab’)2 (pink bars) at 18 to 20 h afterecte
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64There was a significant correlation between val-
ues for %ID/g from the scans (99mTc uptake as Ci
ivided by the volume of 201TI uptake for ischemic
eart slices) versus %ID/g from the well counting of
imilar sections of heart tissue (r 0.85; p 0.007)
Fig. 3B).
Figure 5. Histological Staining
Panels on the left show representative stained sections of the in
(A) than at 48 h (B) after reperfusion. Panels on the right show
with dual rhodamine and 99mTc-anti-RAGE F(ab’)2. Epiﬂuorescent
cardium (C) and adjacent section immunostained for RAGE (D). F
RAGE-speciﬁc staining in the infarcted myocardium. Abbreviation
e 6. Quantitative Histochemical Analysis of the Infarcted
ardial Tissues
was signiﬁcantly higher expression of receptor for advanced gly-
end products (RAGE) and caspase-3 at 18 to 20 h vs. 48 h (p and p  0.01, respectively).Biodistribution of 99mTc-anti-RAGE F(ab’)2
and 99mTc-nonspecific F(ab’)2 in nontarget organs
howed highest accumulation in the liver and spleen
Fig. 4).
Histochemical analyses. Histology of the hearts
showed areas of early infarction in the anterior
wall of the LV. Infarct sizes averaged 13.4 
2.9% (18- to 20-h group) versus 8.9  2.5%
48-h group, p  0.01). Immunohistochemical
taining of the myocardium showed significantly
reater RAGE staining at 18 to 20 h than at 48 h
fter reperfusion, as shown in representative
tained sections from 2 experiments in the left
anel of Figure 5. Histological sections through
he infarcted myocardium of a mouse injected
ith dual rhodamine and 99mTc-anti-RAGE
F(ab’)2 showed colocalization of fluorescence with
AGE staining in the right panel of Figure 5.
Quantitative RAGE staining in the 18- to 20-h
roup was greater than in the 48-h group (12.2 
.9% vs. 7.1  4.3%; p  0.03), and quantitative
aspase staining was also higher at 18 to 20 h than
t 48 h after reperfusion (12.3  2.4% vs. 8.4 
ted myocardium showing greater RAGE staining at 18 to 20 h
l sections through anteroapical infarction in a mouse injected
rograph of 5-m-thick parafﬁn sections of the infarcted myo-
rescence in the myocardium corresponds to localization of
s in Figure 1.farc
seria
mic
luoFigur
Myoc
There
cation2.7%; p  0.01) (Fig. 6).
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65Dual immunofluorescent staining for RAGE-
expressing cells in the infarcted myocardium
showed colocalization of RAGE predominantly
with injured cardiomyocytes undergoing apoptosis
(Fig. 7). RAGE colocalization was also seen with
leukocytes, endothelial cells, and smooth muscle
cells (data not shown).
D I S C U S S I O N
The results of this study demonstrate that RAGE
expression in the myocardium subjected to isch-
emia/reperfusion injury can be imaged and quanti-
fied in live animals with a radiolabeled anti-RAGE
antibody and SPECT imaging. Immunohistology
showed colocalized RAGE expression primarily to
cardiomyocytes and activation of apoptotic path-
ways (caspase staining).
RAGE is a multiligand receptor of the immuno-
globulin superfamily of cell surface molecules.
RAGE was first identified as a cell surface receptor
for the products of nonenzymatic glycation and
oxidation of proteins and lipids that form in such
Figure 7. Representative Dual Immunoﬂuorescent Staining for C
Serial sections stained for receptor for advanced glycation end p
caspase-3 (apoptotic cells, ﬂuorescein isothiocyanate [FITC]), mye
myocytes, FITC), and -myosin antibody (myocyte injury, FITC). C
was performed to identify nuclei. Areas in yellow in the merged imasettings as diabetes, atherosclerosis, renal failure,
aging, and inflammation (2–5). RAGE is expressed
on a variety of cells, including monocytes/
macrophages, T and B lymphocytes, dendritic cells,
endothelial cells, and smooth muscle cells (9,10).
We developed a monoclonal antibody (mAb) di-
rected against a unique peptide sequence on the
V-domain of the extracellular RAGE receptor us-
ing hybridoma technology, have fragmented this
mAb, and have labeled with 99mTc for in vivo
imaging. Using this radiolabeled antibody, we have
shown that RAGE expression in atheroma can be
imaged in apolipoprotein E null (apoE/) mice
and that accelerated atherosclerosis can be detected
in diabetic compared with nondiabetic apoE/
mice (7,8). In this disease model, RAGE staining
colocalized mainly to macrophages. There was no
uptake of 99mTc-labeled anti-RAGE mAb in
AGE null (RAGE/) apoE/ mice.
The biological responses to myocardial ischemic
injury are complex and involve the temporal inter-
play of inflammatory cells, endothelial cells, cardi-
Expressing RAGE in the Infarcted Myocardium
ucts (RAGE) (anti-RAGE, Texas red) were costained with -active
eroxidase (MPO) (leukocytes, FITC), -sarcomeric actin (cardio-
terstaining with 4’,6-diamidino-2-phenylindole (DAPI) (blue)ells
rod
lop
ounges represent colocalization. (Magniﬁcation 400).
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66omyocytes, and cardiac fibroblasts. The fate of
myocardium depends on the length of the ischemic
occlusion, free radical generation, paradoxical vaso-
constriction caused by endothelial dysfunction, and
capillary plugging by neutrophils. Bucciarelli et al.
(1,11) performed a series of experiments looking at
the effects of global ischemia on generation of
RAGE and its ligands in isolated perfused rat and
mouse hearts. After 30 min of ischemia, RAGE
ligands carboxymethyl-lysine advanced glycation
end products (AGEs) increased and corresponded
to increases in lactate dehydrogenase, reduction in
adenosine triphosphate, and fall in LV function.
The presence of AGEs triggers increases in RAGE
expression. This damage was reduced in RAGE/
diabetic hearts and after pre-treatment with soluble
RAGE (s-RAGE) (11).
Aleshin et al. (12) studied RAGE expression in a
mouse model of regional ischemic injury after 30
min of LAD occlusion and found detectable expres-
sion of RAGE by Western blot at 1 h and peak
expression of 3-fold at 6 h after reperfusion. In an
unpublished work, these investigators found persis-
tent expression of 1.7-fold at 48 h (R. Ramasamy,
personal communication, July 2011.). They local-
ized the RAGE expression primarily to cardiomy-
ocytes. To investigate mechanisms for the damag-
ing effects of RAGE, they studied several early
signal transduction pathways linked to activation of
proapoptotic pathways and to RAGE through glu-
cose flux via the polyol pathway to janus kinase–
signal transducer and activator of transcription (13).
They found increased levels of phospho–signal
transducer and activator of transcription 5 and
increased phospho-c-Jun N-terminal kinase (acti-
vated c-Jun N-terminal kinase), both known to
increase reperfusion injury in non–pre-conditioned
hearts (14–16). In further work in cardiomyocytes,
they documented that RAGE/ligand interaction
also mediates hypoxic injury through the Glycogen
synthase kinase–3 pathway (17). Thus up-regulation
f RAGE contributes to myocardial cell death
hrough both ischemia and reperfusion injury path-
ays. Reducing RAGE expression either by knock-
ng out RAGE (RAGE/ mice) or blocking
GEs with a soluble form of RAGE affected all of
hese pathways toward a cardioprotection and re-
uced apoptotic cell death (14–17).
Our results agree with the trends in RAGE
xpression found by Aleshin et al. (12) and dem-xpression in the heart in ischemic injury. We
etected a larger difference in RAGE expression
approximately a 4-fold) between 18 and 20 h.
hese differences in magnitude of change may be
ue to differences in methods of measurement.
estern blot is semiquantitative, whereas the ra-
iotracer method is more quantitative. In addition,
he radiotracer method will detect RAGE expressed
n local circulating inflammatory cells that are
ashed out by the process of tissue extraction prior
o Western blots.
C O N C L U S I O N S
Implications for clinical applications. This is the first
paper to report the feasibility of imaging RAGE
expression in myocardial reperfusion injury using a
novel 99mTc-anti-RAGE F(ab’)2 probe. This non-
invasive approach to quantifying RAGE expression
in myocardial ischemic injury in live animals pro-
vides a model for testing targeted drug therapy to
reduce infarct size. Steps required to develop this
antibody for clinical imaging would first require
producing chimeric or humanized monoclonal an-
tibodies to reduce immunogenicity. Faster blood
pool clearance allowing earlier imaging after injec-
tion could be achieved with smaller fragments such
as single-chain variable fragment antibodies, but the
effect of the smaller agent on uptake at the target
(signal to noise) would need to be determined.
Study limitations. If we had injected the radiola-
beled anti-RAGE antibody earlier in the course of
reperfusion, we may have detected higher levels of
RAGE expression based on the experimental stud-
ies referenced. We considered this but were limited
by the logistics of the model and the relatively slow
blood pool clearance rate of the antibody. A limi-
tation of radiolabeled antibodies is liver uptake, as
shown in the biodistribution data and on the in vivo
scans. A previously published experimental study
documented a low expression of RAGE in the livers
of C57/BL6 mice (18).
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